on BioVersys AG
BioVersys to Present at Stifel 2025 Annual Healthcare Conference
BioVersys AG, a biopharmaceutical company based in Basel, Switzerland, will present its latest clinical and preclinical developments at the Stifel 2025 Annual Healthcare Conference. This event is scheduled to take place from November 11-13, 2025, at the Lotte New York Palace Hotel in New York City.
The presentation will occur on November 12, 2025, at 4:40 PM Eastern Time. The company's CEO, Marc Gitzinger, and CFO, Hernan Levett, will highlight BioVersys's innovations in combating multi-drug resistant bacterial infections. Attendees can view the presentation via webcast with prior registration.
Additionally, the BioVersys management team will conduct one-on-one meetings during the conference. Interested institutional investors are encouraged to schedule these meetings through their conference representatives.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BioVersys AG news